A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma
Qi-Wen Fan(City College of San Francisco), William A. Weiss(City College of San Francisco), Masanori Okaniwa(Takeda (United States)), Shirin Ilkhanizadeh(University of California, San Francisco), Geraldine Cayanan(University of California, San Francisco), Robyn A. Wong(City of Hope), Kevan M. Shokat(Howard Hughes Medical Institute), Erin F. Simonds(St. Jude Children's Research Hospital), W. Clay Gustafson(Revolution Medicines (United States)), Daphne A. Haas‐Kogan(Brigham and Women's Hospital), Ozlem Aksoy(University of California, San Francisco), Theodore Nicolaides(Caris Life Sciences (United States)), Albert Truong(Rice University), Chris J. Novotny(Howard Hughes Medical Institute), Joanna J. Phillips(University of California, San Francisco)
Cited by 182
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k